Position in VCYT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,788,654
+$2,931,226 QoQ
Shares Held
132,618
-12.1% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 367 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $1,773,484,126 across 24 Diagnostics & Research names. VCYT ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,853,198 | $352,997,154 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
667,506 | $334,660,807 | |
| 3 | WAT |
Waters Corp /De/
|
638,786 | $239,570,301 | |
| 4 | RVTY |
Revvity, Inc.
|
1,876,041 | $208,728,321 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
862,704 | $195,652,639 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
353,322 | $186,002,833 | |
| 7 | BLLN |
BillionToOne, Inc.
|
764,215 | $91,690,515 | |
| 8 | NTRA |
Natera, Inc.
|
211,732 | $57,474,650 |
All Filings in VCYT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,788,654 | 132,618 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,857,428 | 150,805 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $213,362 | 5,068 | Shares | Defined | 2026-02-13 | |
| 2024-12-31 | $200,890 | 5,073 | Shares | Defined | 2025-02-13 | |
| 2020-12-31 | $4,000,845 | 81,750 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,462,050 | 45,000 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,813,000 | 70,000 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,701,700 | 70,000 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||